Youngjoo Lee Selected Research

Drug Therapy (Chemotherapy)

1/2021	Sequential Treatment with an Immune Checkpoint Inhibitor Followed by a Small-Molecule Targeted Agent Increases Drug-Induced Pneumonitis.
1/2021	Phase II Study of Pemetrexed as a Salvage Chemotherapy for Thymidylate Synthase-Low Squamous Cell Lung Cancer.
1/2021	Randomized phase II study of platinum-based chemotherapy plus controlled diet with or without metformin in patients with advanced non-small cell lung cancer.
11/2020	First-iGAP: A Randomized Placebo-Controlled Phase II Study of First-line Intercalated Gefitinib and Pemetrexed-Cisplatin Chemotherapy for Never-Smoker Lung Adenocarcinoma Patients.
7/2019	Clinical Implication of HER2 Status in Hormone Receptor-Positive Mucinous Breast Cancer.
10/2013	Impact of EGFR tyrosine kinase inhibitors versus chemotherapy on the development of leptomeningeal metastasis in never smokers with advanced adenocarcinoma of the lung.
12/2012	Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Youngjoo Lee Research Topics

Disease

13	Lung Neoplasms (Lung Cancer) 03/2022 - 03/2012
13	Neoplasms (Cancer) 12/2021 - 07/2014
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 01/2015
4	Disease Progression 02/2022 - 07/2014
4	Breast Neoplasms (Breast Cancer) 07/2019 - 01/2009
4	Neoplasm Metastasis (Metastasis) 10/2017 - 03/2011
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2022 - 01/2021
3	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2017
3	Adenocarcinoma of Lung 11/2020 - 12/2012
3	Hypoxia (Hypoxemia) 02/2012 - 03/2011
2	Adenocarcinoma 04/2022 - 10/2013
2	Pneumonia (Pneumonitis) 01/2022 - 01/2021
2	Body Weight (Weight, Body) 01/2018 - 01/2016
2	Exanthema (Rash) 10/2017 - 03/2012
2	Inflammation (Inflammations) 01/2016 - 06/2012
1	Esophageal Neoplasms (Esophageal Cancer) 04/2022
1	Hypertrophy 01/2022
1	Growth Disorders 01/2022
1	Gastritis 01/2022
1	Lymphatic Metastasis 01/2021
1	Hyperinsulinism (Hyperinsulinemia) 01/2021
1	Meningeal Carcinomatosis 01/2021
1	Organizing Pneumonia 01/2020
1	Infections 12/2019
1	Neuroblastoma 01/2019
1	Carcinogenesis 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 11/2018
1	Hyperlipidemias (Hyperlipidemia) 03/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2017
1	Neurocysticercosis 01/2017
1	Obesity 01/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Dyslipidemias (Dyslipidemia) 01/2016
1	Angiomyolipoma 09/2015
1	Nocardia Infections 12/2014

Drug/Important Bio-Agent (IBA)

9	Tyrosine Kinase InhibitorsIBA 11/2020 - 03/2012
7	Gefitinib (Iressa)FDA Link 03/2022 - 03/2012
6	ErbB Receptors (EGF Receptor)IBA 01/2017 - 03/2012
5	Pharmaceutical PreparationsIBA 01/2022 - 03/2014
4	Immune Checkpoint InhibitorsIBA 02/2022 - 12/2020
4	Cisplatin (Platino)FDA LinkGeneric 11/2020 - 12/2012
3	Biomarkers (Surrogate Marker)IBA 05/2021 - 12/2012
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2016
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2017 - 03/2012
2	pembrolizumabIBA 12/2021 - 12/2020
2	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2015
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2018
2	Pemetrexed (MTA)FDA Link 01/2021 - 11/2020
2	Hormones (Hormone)IBA 07/2019 - 04/2011
2	Gemcitabine FDA Link 10/2013 - 12/2012
2	IronIBA 06/2012 - 06/2011
2	Estrogen ReceptorsIBA 04/2011 - 03/2011
2	Messenger RNA (mRNA)IBA 04/2011 - 01/2009
1	Circulating Tumor DNAIBA 03/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	lazertinibIBA 01/2022
1	Complement C7 (Complement 7)IBA 12/2021
1	capmatinibIBA 10/2021
1	Phosphotransferases (Kinase)IBA 10/2021
1	Glial Fibrillary Acidic ProteinIBA 05/2021
1	PlatinumIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Thymidylate SynthaseIBA 01/2021
1	Cytotoxins (Cytolysins)IBA 01/2021
1	CobaltIBA 01/2021
1	FluorineIBA 12/2020
1	NivolumabIBA 12/2020
1	ceritinibIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2019
1	human ERBB2 proteinIBA 07/2019
1	Trastuzumab (Herceptin)FDA Link 07/2019
1	Apoptosis Regulatory ProteinsIBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	IDF-11774IBA 11/2018
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 11/2018
1	LipidsIBA 01/2018
1	Simvastatin (Zocor)FDA LinkGeneric 10/2017
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2017
1	AfatinibIBA 10/2017
1	CholesterolIBA 03/2017
1	Anaplastic Lymphoma KinaseIBA 01/2017
1	CrizotinibIBA 01/2017
1	HM781-36BIBA 01/2017
1	Atorvastatin (Lipitor)FDA Link 01/2016
1	CytokinesIBA 01/2016
1	Therapeutic UsesIBA 01/2016
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016
1	SteroidsIBA 12/2014

Therapy/Procedure

10	Therapeutics 02/2022 - 03/2012
7	Drug Therapy (Chemotherapy) 01/2021 - 12/2012
2	Proton Therapy 04/2022 - 01/2021
2	Radiotherapy 04/2022 - 01/2021
2	Chemoradiotherapy 04/2022 - 10/2017
2	Aftercare (After-Treatment) 01/2021 - 07/2014
1	Neoadjuvant Therapy 04/2022
1	Fecal Microbiota Transplantation 01/2018
1	Cranial Irradiation 01/2017
1	Nephrectomy 09/2015